
Velakast Tablet is a fixed-dose combination of Sofosbuvir (400 mg) and Velpatasvir (100 mg), used for the treatment of chronic hepatitis C virus (HCV) infection in adults.
| Generic Name | Sofosbuvir 400 mg and Velpatasvir 100 mg |
| Manufacturer | Aprazer Healthcare Pvt Ltd |
| Packing | 28 Tablets |
| Prescribed For | Hepatitis C Virus |
| Availability | In Stock |




As a leading supplier of high-quality generic antiviral medicines, we provide Velakast (Velpatasvir 100mg and Sofosbuvir 400mg) Tablets, widely used for the treatment of chronic Hepatitis C.
We ensure safe, consistent, and timely bulk supply of Hepatitis C drugs, including Sofosbuvir 400 mg / Velpatasvir 100 mg (Generic Epclusa), to hospitals, clinics, pharmacies, healthcare providers, physicians, NGOs, and authorized buyers in over 80 countries worldwide. Our global distribution network spans Latin America, Africa, Asia, Europe, the Middle East, and North America, covering key markets such as Mexico, Brazil, Colombia, Peru, Chile, UAE, Saudi Arabia, Egypt, South Africa, Namibia, Kenya, Nigeria, Singapore, Vietnam, Thailand, the Philippines, Canada, and many more.
Disclaimer
This website operates in compliance with applicable pharmaceutical laws. All content and data available on this website are intended solely for informational purposes. The information provided is not a substitute for professional medical advice, diagnosis, or treatment. Information provided here is for general awareness and does not replace medical advice. We strongly encourage you to consult a qualified healthcare professional for guidance.